tiprankstipranks
Raymond James downgrades Disc Medicine to Outperform on mixed study results
PremiumThe FlyRaymond James downgrades Disc Medicine to Outperform on mixed study results
1M ago
Disc Medicine downgraded to Outperform from Strong Buy at Raymond James
PremiumThe Fly
Disc Medicine downgraded to Outperform from Strong Buy at Raymond James
1M ago
Disc Medicine announces Phase 2 AURORA study met primary endpoint
PremiumThe Fly
Disc Medicine announces Phase 2 AURORA study met primary endpoint
1M ago
Disc Medicine price target raised to $80 from $70 at BMO Capital
PremiumThe FlyDisc Medicine price target raised to $80 from $70 at BMO Capital
2M ago
Disc Medicine Appoints New CCO With Inducement Grant
PremiumCompany Announcements
Disc Medicine Appoints New CCO With Inducement Grant
2M ago
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer
PremiumPress Releases
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer
2M ago
Disc Medicine receives FDA Orphan Drug Designation for DISC-3405
PremiumThe FlyDisc Medicine receives FDA Orphan Drug Designation for DISC-3405
3M ago
Disc Medicine’s treatment of Polycythemia Vera gets FDA orphan designation
PremiumThe Fly
Disc Medicine’s treatment of Polycythemia Vera gets FDA orphan designation
3M ago
Disc Medicine Announces Executive Team Changes
PremiumCompany Announcements
Disc Medicine Announces Executive Team Changes
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100